在结直肠癌转移中的外体非编码RNA
Xiaoqian Yu1, Chiwen Bu2, Xuejie Yang1
1Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Clinica chimica acta; international journal of clinical chemistry
|February 28, 2024
概括
结肠直肠癌 (CRC) 的转移机制尚不清楚. 外体非编码RNAs (ncRNAs) 是CRC的关键驱动因素和潜在生物标志物,提供新的治疗和诊断途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 大肠直肠癌 (CRC) 的发病率和死亡率很高,经常因远程转移而复杂化.
- 瘤转移显著降低了CRC患者的生存率和治疗疗效.
- 驱动CRC转移的精确分子机制在很大程度上仍未确定.
研究的目的:
- 研究外体非编码RNAs (ncRNAs) 在结直肠癌 (CRC) 转移中的作用.
- 探索外体ncRNAs作为治疗点和CRC转移的生物标记物的潜力.
主要方法:
- 对非编码RNAs (ncRNAs) 的外体介导转移进行分析.
- 研究参与瘤转移的关键分子和信号通路的ncRNA调节.
- 评估外体ncRNAs作为潜在的诊断生物标志物 (液体活检).
主要成果:
- 外基因组促进了参与瘤发生的非编码RNA (ncRNA) 的传播.
- 外体ncRNAs在调节CRC转移方面发挥着关键作用.
- 这些ncRNA显示出作为CRC敏感和特定生物标志物的潜力.
结论:
- 外体的ncRNAs是结直肠癌 (CRC) 转移的关键调节者.
- 向外体ncRNAs为CRC提供了一个有前途的治疗策略.
- 外体ncRNAs代表了早期诊断和监测CRC转移的有价值的生物标志物.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


